The B. Braun Group is a German company that manufactures medical and pharmaceutical devices. The company has offices and facilities located in more than 60 countries around the world. This company has its headquarters in Melsungen, which is located in central Germany. Established in 1839, the company is still owned by the Braun family. There are approximately 5.000 available products by B Braun in the healthcare sector, 95% of which are manufactured in-house. Medical and surgical equipment is manufactured by the company for clients around the globe.
It operates through four business divisions.
These are Hospital Care (which manufactures anaesthesia and infusion equipment, catheters, and IV solutions); Aesculap (this division produces surgical instruments, sutures and orthopedic implants); Out Patient Market (which pertains to wound care, diabetes and nutrition products); and B. Braun Avitum (which specialises in dialysis products). Additionally, the company provides contract manufacturing services as well as operating dialysis clinics in Europe. B. Braun intends to continue to run as a family business. B. Braun specialises in the following areas of medical care:
-Continence Care & Urology
-Degenerative Spinal Disorders
-Extracorporeal Blood Treatment
-Orhopaedic Joint Replacement
As part of its range of medical devices, B. Braun offers adaptable products which can be combined to create a flexible infusion system, ranging from venous puncture to drug admixture and infusion. The products have modular components, allowing them to be put together to create effective and personalised infusion systems. With virtually endless design options, standard products can be used in assemblies and packed in customised kits. It is also possible to use device components from completely different therapy fields to create a hybrid medical device for the individual clinician’s needs.
Xperius™ is a sophisticated ultrasound system developed in collaboration between B. Braun and Philips, manufactured to meet the needs of regional anaesthesia and vascular access. Ultrasound-guided regional anaesthesia, including peripheral nerve blocks and neuraxial applications, and ultrasound-assisted vascular access, such as CVC, PICC, IVC placements, and arterial accesses, are typically performed using the Xperius™ device. Additionally, it can be used as a method for abdominal examinations, lung scans, and other diagnostic procedures.
The Dialog iQ is a dialysis system with two biological inputs which improve information on the patient’s hemodynamic condition. It has the capability of achieving appropriate dialysis doses for all patients as well as all treatment modes (SNCO, HD, HDF), and is designed to be intuitive, adaptable and easy-to-use. One of the main advantages of the Dialog iQ is the machine’s rapid preparation capabilities, as the setting of the machine and its rinse out of the blood and dialysate circuit occur in a single step.
August 2, 2021